查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1386215

全球活细胞成像市场：趋势、预测和竞争分析（~2030 年）

Live Cell Imaging Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

活细胞成像趋势和预测

预计到2030年，全球活细胞成像市场规模将达到约58.7亿美元，2024年至2030年年复合成长率为11.1%。这个市场的主要驱动因素是在药物研发中越来越多地采用高内涵筛选技术、增加癌症发生率以及增加政府对细胞研究的资助。全球活细胞成像市场的未来可能包括细胞生物学、干细胞、发育生物学和药物研发市场的商机。

活细胞成像市场洞察

Lucintel 预测，在预测期内，设备仍将是最大的细分市场，因为它有助于提供有关细胞和组织功能基本性质的重要见解。

在这个市场中，干细胞可能仍然是最大的细分市场，因为它们具有独特的自我更新和分化成不同细胞类型的能力，导致它们在细胞替代和组织工程疗法中的应用越来越广泛。

由于医疗基础设施和研发活动投资增加，以及这些成像技术在精准医学和药物研发应用中的采用不断增加，预计亚太地区在预测期内将出现最高成长。

市场规模/估计：活细胞成像的货币估计市场金额（10 亿美元）

趋势和预测分析：各细分市场和地区的市场趋势（2018-2023）和预测（2024-2030）

細項分析：按产品和服务、技术、应用、最终用途和地区等各个细分市场的金额（十亿美元）估算活细胞成像市场。

区域分析：北美、欧洲、亚太地区和世界其他地区的活细胞成像市场细分

成长机会：按产品/服务、技术、应用、最终用途和地区分類的活细胞成像市场成长机会分析

策略分析：活细胞成像市场併购、新产品开发、竞争形势等。

基于波特五力模型的产业竞争实力分析

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2.哪个细分市场将以更快的速度成长？为什么？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
  • Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q.11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球活细胞影像市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业驱动因素与挑战

第3章2018-2030年市场趋势与预测分析

  • 宏观经济趋势（2018-2023）与预测（2024-2030）
  • 全球活细胞成像市场趋势（2018-2023）与预测（2024-2030）
  • 全球活细胞成像市场：按产品和服务分类
    • 装置
    • 消耗品
    • 软体
    • 服务
    • 其他的
  • 全球活细胞成像市场：依技术分类
    • Time-Lapse Microscopy
    • Fluorescence Resonance Energy Transfer
    • Fluorescence Recovery After Photobleaching
    • High Content Screening
    • 其他的
  • 全球活细胞成像市场：依应用分类
    • 细胞生物学
    • 干细胞
    • 发育生物学
    • 药物研发
    • 其他的
  • 全球活细胞成像市场：依最终用途分类
    • 製药和生物技术公司
    • 学术研究所
    • 合约研究组织
    • 其他的

第4章市场趋势与预测分析：按地区（2018-2030）

  • 全球活细胞成像市场：按地区
  • 北美活细胞成像市场
  • 欧洲活细胞成像市场
  • 亚太地区活细胞影像市场
  • 其他地区活细胞成像市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 全球活细胞成像市场按产品和服务的成长机会
    • 全球活细胞成像市场的技术成长机会
    • 全球活细胞成像市场成长机会（按应用）
    • 按最终用途分類的全球活细胞成像市场成长机会
    • 全球活细胞成像市场按地区成长机会
  • 全球活细胞成像市场的新兴趋势
  • 战略分析
    • 新产品开发
    • 扩大全球活细胞成像市场的产能
    • 全球活细胞成像市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • Danaher
  • ZEISS
  • Nikon Corporation
  • Olympus Corporation
  • PerkinElmer
  • Sartorius
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Etaluma
  • CytoSMART Technologies
简介目录

Live Cell Imaging Trends and Forecast

The future of the global live cell imaging market looks promising with opportunities in the cell biology, stem cell, developmental biology, and drug discovery markets. The global live cell imaging market is expected to reach an estimated $5.87 billion by 2030 with a CAGR of 11.1% from 2024 to 2030. The major drivers for this market are increasing adoption of high-content screening techniques in drug discovery, growing incidence of cancer, and rising government funds for cell-based research.

A more than 150-page report is developed to help in your business decisions.

Live Cell Imaging by Segment

The study includes a forecast for the global live cell imaging by product & service, technology, application, end use, and region.

Live Cell Imaging Market by Product & Service [Shipment Analysis by Value from 2018 to 2030]:

  • Instruments
  • Consumables
  • Software
  • Services
  • Others

Live Cell Imaging Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Time-Lapse Microscopy
  • Fluorescence Resonance Energy Transfer
  • Fluorescence Recovery After Photobleaching
  • High Content Screening
  • Others

Live Cell Imaging Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Cell Biology
  • Stem Cells
  • Developmental Biology
  • Drug Discovery
  • Others

Live Cell Imaging Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Pharmaceutical & Biotechnology Companies
  • Academic and Research Institutes
  • Contract Research Organisations
  • Others

Live Cell Imaging Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Live Cell Imaging Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies live cell imaging companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the live cell imaging companies profiled in this report include-

  • Danaher
  • Zeiss
  • Nikon Corporation
  • Olympus Corporation
  • Perkinelmer
  • Sartorius
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Etaluma
  • Cytosmart Technologies

Live Cell Imaging Market Insights

Lucintel forecasts that instruments will remain the largest segment over the forecast period as it helps in providing critical insights into the fundamental nature of cellular and tissue function.

Within this market, stem cell will remain the largest segment due to its increasing adoption in cell replacement and tissue engineering therapies owing to their unique abilities to self-renew and differentiate into diverse cell types.

APAC is expected to witness highest growth over the forecast period due to growing investment in the healthcare infrastructure and research & development activities and increasing adoption of these imaging techniques in precision medicine and drug discovery applications.

Features of the Global Live Cell Imaging Market

Market Size Estimates: Live cell imaging market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Live cell imaging market by various segments, such as by product & service, technology, application, end use and region in terms of($B).

Regional Analysis: Live cell imaging market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product & services, technologies, applications, end uses, and regions for the live cell imaging market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the live cell imaging market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the live cell imaging market size?

Answer: The global live cell imaging market is expected to reach an estimated $5.87 billion by 2030.

Q.2 What is the growth forecast for live cell imaging market?

Answer: The global live cell imaging market is expected to grow with a CAGR of 11.1% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the live cell imaging market?

Answer: The major drivers for this market are increasing adoption of high-content screening techniques in drug discovery, growing incidence of cancer, and rising government funds for cell-based research.

Q4. What are the major segments for live cell imaging market?

Answer: The future of the live cell imaging market looks promising with opportunities in the cell biology, stem cell, developmental biology, and drug discovery markets.

Q5. Who are the key live cell imaging market companies?

Answer: Some of the key live cell imaging companies are as follows:

  • Danaher
  • ZEISS
  • Nikon Corporation
  • Olympus Corporation
  • PerkinElmer
  • Sartorius
  • Agilent Technologies
  • Thermo Fisher Scientific
  • Etaluma
  • CytoSMART Technologies

Q6. Which live cell imaging market segment will be the largest in future?

Answer: Lucintel forecasts that instruments will remain the largest segment over the forecast period as it helps in providing critical insights into the fundamental nature of cellular and tissue function.

Q7. In live cell imaging market, which region is expected to be the largest in next 5 years?

Answer: APAC is expected to witness highest growth over the forecast period due to growing investment in the healthcare infrastructure and research & development activities and increasing adoption of these imaging techniques in precision medicine and drug discovery applications.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the live cell imaging market by product & service (instruments, consumables, software, services, and others), technology (time-lapse microscopy, fluorescence resonance energy transfer, fluorescence recovery after photobleaching, high content screening, and others), application (cell biology, stem cells, developmental biology, drug discovery, and others), end use (pharmaceutical & biotechnology companies, academic and research institutes, contract research organisations, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Live Cell Imaging Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Live Cell Imaging Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Live Cell Imaging Market by Product & Service
    • 3.3.1: Instruments
    • 3.3.2: Consumables
    • 3.3.3: Software
    • 3.3.4: Services
    • 3.3.5: Others
  • 3.4: Global Live Cell Imaging Market by Technology
    • 3.4.1: Time-Lapse Microscopy
    • 3.4.2: Fluorescence Resonance Energy Transfer
    • 3.4.3: Fluorescence Recovery After Photobleaching
    • 3.4.4: High Content Screening
    • 3.4.5: Others
  • 3.5: Global Live Cell Imaging Market by Application
    • 3.5.1: Cell Biology
    • 3.5.2: Stem Cells
    • 3.5.3: Developmental Biology
    • 3.5.4: Drug Discovery
    • 3.5.5: Others
  • 3.6: Global Live Cell Imaging Market by End Use
    • 3.6.1: Pharmaceutical & Biotechnology Companies
    • 3.6.2: Academic and Research Institutes
    • 3.6.3: Contract Research Organisations
    • 3.6.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Live Cell Imaging Market by Region
  • 4.2: North American Live Cell Imaging Market
    • 4.2.2: North American Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others
  • 4.3: European Live Cell Imaging Market
    • 4.3.1: European Live Cell Imaging Market by Product & Service: Instruments, Consumables, Software, Services, and Others
    • 4.3.2: European Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others
  • 4.4: APAC Live Cell Imaging Market
    • 4.4.1: APAC Live Cell Imaging Market by Product & Service: Instruments, Consumables, Software, Services, and Others
    • 4.4.2: APAC Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others
  • 4.5: ROW Live Cell Imaging Market
    • 4.5.1: ROW Live Cell Imaging Market by Product & Service: Instruments, Consumables, Software, Services, and Others
    • 4.5.2: ROW Live Cell Imaging Market by Application: Cell Biology, Stem Cells, Developmental Biology, Drug Discovery, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Live Cell Imaging Market by Product & Service
    • 6.1.2: Growth Opportunities for the Global Live Cell Imaging Market by Technology
    • 6.1.3: Growth Opportunities for the Global Live Cell Imaging Market by Application
    • 6.1.4: Growth Opportunities for the Global Live Cell Imaging Market by End Use
    • 6.1.5: Growth Opportunities for the Global Live Cell Imaging Market by Region
  • 6.2: Emerging Trends in the Global Live Cell Imaging Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Live Cell Imaging Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Live Cell Imaging Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Danaher
  • 7.2: ZEISS
  • 7.3: Nikon Corporation
  • 7.4: Olympus Corporation
  • 7.5: PerkinElmer
  • 7.6: Sartorius
  • 7.7: Agilent Technologies
  • 7.8: Thermo Fisher Scientific
  • 7.9: Etaluma
  • 7.10: CytoSMART Technologies